Karyopharm Therapeut
(KPTI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -109,576 | -66,161 | -178,407 | -120,197 | -72,114 |
| Depreciation Amortization | 3,012 | 1,427 | 2,184 | 821 | 623 |
| Accounts payable and accrued liabilities | -3,171 | -2,016 | -1,380 | -3,425 | -1,870 |
| Other Working Capital | -16,286 | -5,796 | -169 | -4,947 | -9,393 |
| Other Operating Activity | 11,194 | 5,923 | 18,655 | 16,803 | 10,474 |
| Operating Cash Flow | $-114,827 | $-66,623 | $-159,117 | $-110,945 | $-72,280 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -49 | -49 | -2,363 | -1,270 | -779 |
| Purchase Of Investment | -46,668 | -27,993 | -242,811 | -97,662 | -74,943 |
| Sale Of Investment | 118,511 | 60,033 | 137,510 | 94,378 | 50,602 |
| Investing Cash Flow | $71,794 | $31,991 | $-107,664 | $-4,554 | $-25,120 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 166,885 | N/A | N/A |
| Common Stock Issued | 547 | 152 | 149,224 | 148,333 | 147,561 |
| Financing Cash Flow | $547 | $152 | $316,109 | $148,333 | $147,561 |
| Exchange Rate Effect | 9 | -37 | -78 | -9 | -44 |
| Beginning Cash Position | 118,737 | 118,737 | 69,487 | 69,487 | 69,487 |
| End Cash Position | 76,260 | 84,220 | 118,737 | 102,312 | 119,604 |
| Net Cash Flow | $-42,477 | $-34,517 | $49,250 | $32,825 | $50,117 |
| Free Cash Flow | |||||
| Operating Cash Flow | -114,827 | -66,623 | -159,117 | -110,945 | -72,280 |
| Capital Expenditure | -49 | -49 | -2,363 | -1,270 | -779 |
| Free Cash Flow | -114,876 | -66,672 | -161,480 | -112,215 | -73,059 |